01 4ITERUM THERAP
01 17795243
02 111478428
03 111554112
04 112109197
01 1Y
02 3Blank
01 2Y
02 2Blank
01 12029-06-03
02 22039-04-01
03 12039-12-23
Patent Expiration Date : 2039-04-01
PROBENECID; SULOPENEM ETZADROXIL
US Patent Number : 12109197
Drug Substance Claim :
Drug Product Claim :
Application Number : 213972
Patent Use Code : U-4026
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2039-04-01
Patent Expiration Date : 2039-04-01
PROBENECID; SULOPENEM ETZADROXIL
US Patent Number : 11554112
Drug Substance Claim :
Drug Product Claim :
Application Number : 213972
Patent Use Code : U-4026
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2039-04-01
Patent Expiration Date : 2039-12-23
PROBENECID; SULOPENEM ETZADROXIL
US Patent Number : 11478428
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 213972
Patent Use Code : U-4026
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2039-12-23
Patent Expiration Date : 2029-06-03
PROBENECID; SULOPENEM ETZADROXIL
US Patent Number : 7795243
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 213972
Patent Use Code : U-4026
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-06-03
